Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Abstract

Letters11 November 2020Sixty-Day Outcomes Among Patients Hospitalized With COVID-19FREEVineet Chopra, MD, MSc, Scott A. Flanders, MD, Megan O’Malley, PhD, Anurag N. Malani, MD, and Hallie C. Prescott, MD, MScVineet Chopra, MD, MScUniversity of Michigan Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganSearch for more papers by this author, Scott A. Flanders, MDUniversity of Michigan Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganSearch for more papers by this author, Megan O’Malley, PhDUniversity of Michigan Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganSearch for more papers by this author, Anurag N. Malani, MDSt. Joseph Mercy Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganSearch for more papers by this author, and Hallie C. Prescott, MD, MScUniversity of Michigan Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M20-5661 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Although characteristics and in-hospital outcomes for persons with coronavirus disease 2019 (COVID-19) have been well described, less is known about the longer-term outcomes of hospitalized patients.Objective: To describe 60-day postdischarge clinical, financial, and mental health outcomes of patients with COVID-19.Methods: This observational cohort study looked at patients hospitalized with COVID-19 (discharged between 16 March and 1 July 2020) at 38 hospitals participating in the MI-COVID19 initiative. The aim of MI-COVID19, a Michigan statewide collaboration sponsored by Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network, is to improve care for patients hospitalized with COVID-19. Trained quality abstractors (often registered nurses) collect data from patient medical records using structured templates. For hospitals unable to abstract all COVID-19 hospitalizations, a sample is selected for inclusion by using a pseudo-randomization procedure (minute of hospital discharge).At 60 days after discharge, abstractors review the medical record to collect data on clinical events, including readmission (to the index hospital or any hospital viewable in the medical record) and postdischarge death. In addition, for all patients alive and not residing in a health care or correctional facility, abstractors contact patients by telephone to complete a survey about primary care follow-up, ongoing cardiopulmonary symptoms, return to normal activity, financial impact, and emotional and mental health outcomes. At least 3 attempts are made to contact patients. The study was deemed “not regulated” by the University of Michigan institutional review board (HUM 00179611).Findings: Of 1648 patients with COVID-19 admitted to 38 hospitals, 398 (24.2%) died during hospitalization and 1250 (75.8%) survived. Of 1250 patients discharged alive, 975 (78.0%) went home whereas 158 (12.6%) were discharged to a skilled nursing or rehabilitation facility (Table 1). By 60 days after discharge, an additional 84 patients (6.7% of hospital survivors and 10.4% of intensive care unit [ICU]-treated hospital survivors) had died, bringing the overall mortality rate for the cohort to 29.2%, and 63.5% for the 405 patients who received treatment in an ICU. Within 60 days of discharge, 189 patients (15.1% of hospital survivors) were rehospitalized.Table 1. Demographic and Clinical Characteristics of 1250 Survivors of COVID-19 HospitalizationOf patients alive 60 days after discharge, 488 (41.8%) were successfully contacted and completed the 60-day postdischarge telephone survey. Of these, 265 reported seeing a primary care physician within 2 weeks (Table 2). Most follow-up visits (304 of 382) occurred virtually by videoconference (161 of 382) or telephone (143 of 382), whereas 77 occurred in person and 1 was of unknown format.Table 2. 60-Day Outcomes Among 1250 Survivors of COVID-19 Hospitalization, 488 of Whom Completed the Telephone SurveyCardiopulmonary symptoms (such as cough and dyspnea) were reported by 159 patients, including 92 with new or worsening symptoms and 65 with persistent loss of taste or smell. Fifty-eight patients reported new or worsening difficulty completing activities of daily living. Among 195 patients who were employed before hospitalization, 117 had returned to work whereas 78 could not because of ongoing health issues or job loss. Of the 117 patients who returned to work, 30 reported reduced hours or modified duties due to health reasons.Nearly half of all patients (238 of 488) reported being emotionally affected by their health, and 28 sought care for mental health after discharge. Moreover, 179 patients reported at least a mild financial impact from their hospitalization, with 47 reporting use of most or all of their savings and 35 rationing food, heat, housing, or medications due to cost.Discussion: In this multihospital cohort of patients hospitalized with COVID-19 in Michigan, nearly 1 in 3 patients died during hospitalization or within 60 days of discharge. For most patients who survived, ongoing morbidity, including the inability to return to normal activities, physical and emotional symptoms, and financial loss, was common (1). These data confirm that the toll of COVID-19 extends well beyond hospitalization, a finding consistent with long-term sequelae from sepsis (2) and other severe respiratory viral illnesses (3). Although most patients saw a primary care provider after discharge, 1 in 5 had no primary care follow-up visit within 60 days of discharge. Collectively, these findings suggest that better models to support COVID-19 survivors are necessary (4).Our study has limitations. Although postdischarge chart review was completed for all patients, telephone contact occurred in fewer than half. Loss to follow-up may be nonrandom; thus, the proportion of patients who had adverse outcomes may be biased. We therefore report numbers of events, which should be interpreted as the minimum known number of patients with a given outcome. Despite these limitations, our study conveys that adverse events after COVID-19 hospitalization are common. Policies and clinical and research programs targeting these aspects are needed.References1. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603-5. [PMID: 32644129] doi:10.1001/jama.2020.12603 CrossrefMedlineGoogle Scholar2. Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. 2018;319:62-75. [PMID: 29297082] doi:10.1001/jama.2017.17687 CrossrefMedlineGoogle Scholar3. Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med. 2020;52:jrm00063. [PMID: 32449782] doi:10.2340/16501977-2694 MedlineGoogle Scholar4. Prescott HC, Girard TD. Recovery from severe COVID-19: leveraging the lessons of survival from sepsis. JAMA. 2020;324:739-40. [PMID: 32777028]doi:10.1001/jama.2020.14103 CrossrefMedlineGoogle Scholar Comments 0 Comments Sign In to Submit A Comment Steve Caritas, Professor Emeritus of Maternal Fetal Medicine, Magee-Women's Hospital, University of School of MedicineUniversity of Pittsburgh School of Medicine16 November 2020 Pennsylvania licensed physician My comment is quite short. After reviewing all charts and grafts for treatment: There is absolutely no documentation of all the various OUTPATIENT treatments available prior to hospitalization that may well have precluded becoming an inpatient. I find this totally unacceptable. Dr Joseph BellIHS23 December 2020 Follow up on comment Thank you Dr Caritas for your comment-- could you share the names of various outpatient medications that may be effective? Author, Article, and Disclosure InformationAuthors: Vineet Chopra, MD, MSc; Scott A. Flanders, MD; Megan O’Malley, PhD; Anurag N. Malani, MD; Hallie C. Prescott, MD, MScAffiliations: University of Michigan Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganSt. Joseph Mercy Health System and The Michigan Hospital Medicine Safety Collaborative, Ann Arbor, MichiganAcknowledgment: The authors thank all the BCBSM Collaborative Quality Initiatives that partnered together on data collection and all the hospitals that volunteered to be part of MI-COVID19.Financial Support: From BCBSM and Blue Care Network as part of the BCBSM Value Partnerships program.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-5661.Reproducible Research Statement: Study protocol: Information available at https://mi-hms.org/quality-initiatives/mi-covid19-initiative. Statistical code: Available on request from Dr. O’Malley (e-mail, [email protected]). Data set: Not available.Corresponding Author: Vineet Chopra, MD, MSc, 2800 Plymouth Road, Building 16, #432 W, Ann Arbor, MI 48109; e-mail, [email protected] article was published at Annals.org on 11 November 2020. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPathogenesis of Pulmonary Long COVID-19The effect of COVID-19 on cancer immunotherapy and cancer careLong COVID-19 Syndrome and Sudden Cardiac Death: The Phantom MenaceThe potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United StatesIntrinsic factors behind long COVID: III. Persistence of SARS‐CoV‐2 and its componentsCardiopulmonary, Functional, Cognitive and Mental Health Outcomes Post-COVID-19, Across the Range of Severity of Acute Illness, in a Physically Active, Working-Age PopulationHealthcare utilization and adverse outcomes stratified by sex, age and long-term care residency using the Alberta COVID-19 Analytics and Research Database (ACARD): a population-based descriptive studyBurden of long COVID among adults experiencing sheltered homelessness: a longitudinal cohort study in King County, WA between September 2020—April 2022Healthcare use attributable to COVID-19: a propensity-matched national electronic health records cohort study of 249,390 people in Wales, UKPost COVID-19 condition and health-related quality of life: a longitudinal cohort study in the Belgian adult populationThe plasma metabolome of long COVID patients two years after infectionThe long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVIDRisk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospitalCOVID persistente: prevalencia, seguimiento y uso de recursos en Atención PrimariaEffect of different types of supervised exercise programs on cardiorespiratory and muscular fitness, pain, fatigue, mental health and inflammatory and oxidative stress biomarkers in older patients with post-COVID-19 sequelae “EJerSA-COVID-19”: a randomized controlled trialEndocarditis caused by Aspergillus fumigatus in a patient 9 months after COVID-19 infection recovery: a case report and review of the literatureIncidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysisEffects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with post‐ COVID ‐19 sequelae: A randomized controlled trialInsights into the epidemiology and clinical aspects of post-COVID-19 conditions in adultImpact of rehabilitation measures on patients, who have undergone COVID-19, in post-acute periodManagement of Diabetes Complications During and After COVID-19Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary EmbolismFactors Contributing to Delayed Return to Work among French Healthcare Professionals Afflicted by COVID-19 at a Hospital in the Rhône-Alpes Region, 2021Postacute coronavirus disease‐2019 syndrome: Review of the literature and role of the pharmacistPost COVID-19 complications and follow up biomarkersComprehensive Risk Assessment of Infection Induced by SARS-CoV-2Post-COVID-19 fatigue and health-related quality of life in Saudi Arabia: a population-based studyA Prospective Study of Patients with Persistent Symptoms after SARS-CoV-2 Infection Referred to Physical Medicine and RehabilitationSolanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidateLong COVID-19 Pathophysiology: What Do We Know So Far?Prevalence and risk factors of psychological symptoms and quality of life in COVID‐19 survivors: A cross‐sectional study of three different populationsReported long-term effects of COVID-19 patients after hospital discharge in JordanLong COVID: what is known and what gaps need to be addressedPulmonary rehabilitation in post COVID-19 syndromeImplementing a Multidisciplinary Post-COVID Clinic in a Small Community EnvironmentLong COVID: Clinical Findings, Pathology, and Endothelial Molecular MechanismsTCM “medicine and food homology” in the management of post-COVID disordersWorkplace factors that promote and hinder work ability and return to work among individuals with long-term effects of COVID-19: A qualitative studyLong term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort studyReview of Hyperpolarized Pulmonary Functional 129 Xe MR for Long‐COVIDLong COVID Incidence in a Large US Ambulatory Electronic Health Record SystemCOVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and TreatmentInfluence of vaccination on adverse health outcomes after SARS‐CoV‐2 infection among individuals with alcohol use disorder: a population‐based studyReadmissions for Myocardial Infarction Among Survivors of COVID-19 HospitalizationThe SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese micePost-COVID-19 Syndrome and Related Dysautonomia: Reduced Quality of Life, Increased Anxiety and Manifestation of Depressive Symptoms: Evidence from GreeceMyocarditis and Myocardial Injury in Long COVID Syndrome: A Comprehensive Review of the LiteratureImpact of COVID-19 on employment: sociodemographic, medical, psychiatric and neuropsychological correlatesImmunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 ConditionsComparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection30-Day Cardiovascular Readmissions Following Discharge With COVID-19: A US Nationwide Readmission Database Analysis From the Pandemic Year 2020Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluationTransitional and aftercare needs of persons recovering from COVID ‐19 using the Omaha System: A Scoping ReviewPost-COVID-19 and Mental HealthPotential Impact of Long COVID-19 on Orthodontic TreatmentThe role of immune activation and antigen persistence in acute and long COVIDPost-COVID-19 Syndrome in Neurology Patients: A Single Center ExperienceRadiological lung sequelae, functional status and symptoms in older patients 3 and 6 months after hospitalization for COVID-19 pneumoniaCardiovascular Considerations in the Management of People With Suspected Long COVIDPost-COVID Interstitial Lung Disease and Other Lung SequelaeClinical characterization and factors associated with quality of life in Long COVID patients: Secondary data analysis from a randomized clinical trialPost-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patientsAcute inpatient rehabilitation for COVID-19 survivors: A retrospective case seriesPost-COVID Symptoms in Occupational Cohorts: Effects on Health and Work AbilityFactors associated with oxygen requirement and persistent symptoms 1 year after severe COVID-19 infectionEuropean Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19Post-COVID impact: Misery of the indisposedThe presence of symptoms within 6 months after COVID-19: a single-center longitudinal studyRevisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of DrugsLong COVID and rehabilitationImpact of heart failure on all‐cause mortality in COVID‐19: findings from the Eurasian International RegistryLong COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factorsPrevalence of Post Recovery Symptoms among Recovered Cases of COVID-19 in PakistanLong COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial DiseasesSARS-COV-2 Pandemic: How to Maintain a COVID-free HospitalDietary Intake in Older Patients with Dementia Prior to and After the Onset of Coronavirus Disease 2019Neurological manifestations of long COVID: clinical aspects and impact on quality of lifePost Acute Corona Virus (Covid-19) SyndromeLong COVID Clinical ManifestationsOne-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance DatabasePsychological Wellbeing and Perceived Fatigue in Competitive Athletes after SARS-CoV-2 Infection 2 Years after Pandemic Start: Practical IndicationsEpidemiology and Clinical Presentation of COVID-19 in Older AdultsThe Very Long COVID: Persistence of Symptoms after 12–18 Months from the Onset of Infection and HospitalizationExercise tolerance, fatigue, mental health, and employment status at 5 and 12 months following COVID-19 illness in a physically trained populationPhysical function and fatigue recovery at 6 months after hospitalization for COVID ‐19Post–Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records–Based StudyRationale, Design, and Characteristics of the VALIANT (COVID‐19 in Older Adults: ALongitudinal Assessment) CohortPOST-COVID SYNDROME, ETIOPATOGENESIS OF ORGANS DEFECTS IN CHILDREN LIVING IN THE CONDITIONS OF LOCAL MILITARY CONFLICTClinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients Admitted to Hospital With Coronavirus Disease 2019 (COVID-19)Clinical Anatomical Characteristics of Patients with Rhino-Orbit-Cerebral MucormycosisPrevalence, Patterns, and Clinical Severity of Long COVID among Chinese Medicine Telemedicine Service Users: Preliminary Results from a Cross-Sectional StudyShort- and long-term noninvasive cardiopulmonary exercise assessment in previously hospitalised COVID-19 patientsPresence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort studyRole of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic ReviewAssessment of and in Patients Hospitalized for COVID-19 at 6 of in COVID-19 of pain, fatigue, and function between and fatigue syndrome: a survey effects of COVID‐19 in patients hospitalized during the first of the The impact of persistent fatigue on quality of life in a cross‐sectional impact of COVID-19 by life years at national in in of after a new coronavirus infection ICU and Critical Care Analysis of in an International of with a of COVID-19 and and Cognitive Among Patients for Post-COVID An COVID: A for of in and of the post-COVID syndrome and Acute Respiratory Syndrome and Risk for Long COVID Symptoms: impact of COVID-19 pandemic on the quality of life of healthcare and the associated A systematic Care and Post-COVID-19 symptoms and recovery in hospitalized mild and COVID-19 Acute Respiratory Syndrome and features of the post-COVID syndrome for the Pulmonary of After for COVID-19: for a Scoping long-term effects of COVID-19 on pulmonary status and quality of Cases of with OF COVID-19 follow-up of the randomized for plasma in severe COVID-19 medical on and Post-COVID of pain after for COVID-19 a analysis of functional quality of and mental health after COVID-19 COVID: healthcare utilization and medical 6 months of fatigue syndrome among long COVID-19 patients: A systematic review and and respiratory of patients for COVID-19: for a observational of patients with post COVID-19 use of by in and quality of life and of health following COVID-19 infection in a of COVID-19 antigen programs in the the clinical, and during the different COVID-19 disease using COVID in COVID-19 COVID and in a sample of in the first year of the electronic health post-acute sequelae of COVID-19 rehabilitation for people severe case and literature syndrome: assessment of and long-term symptoms in in Saudi COVID-19 and Heart A of and Persistence of Symptoms in after Recovery from of in Hospitalized COVID-19 Patients: A Systematic Review and of in patients after in the Care of Patients with with COVID-19: of sequelae of COVID-19 a review of and for observational research on long-term of after a new coronavirus infection of post COVID effect of on pulmonary function in post recovery COVID-19 patients with pulmonary to in a COVID study research protocol: Prospective cohort study of COVID-19 of Disease 2019 (COVID-19) Condition or Long COVID: A and Systematic COVID-19 syndrome: a longitudinal study during the two first in and for a for in the of the Risk after COVID-19 A Analysis by with for hospitalized COVID-19 patients: a cardiac and outcomes of COVID-19 COVID-19 of With Persistent and Respiratory Following COVID-19 in 2020 and to work and the impact of post COVID-19 A systematic for in Hospitalized Patients With COVID‐19: A associated with readmission following index coronavirus disease 2019 (COVID-19) A retrospective cohort study of patients in the United manifestations in patients with new coronavirus infection COVID-19 Syndrome Severe Long COVID-19: An of COVID-19 among previously hospitalized patients up to 1 year after a systematic review and for Post-Acute or Cognitive of SARS-CoV-2 A 2 Clinical Study and Quality of at Work in Patients after Management of in COVID-19 Patients Referred to a Cardiac Center after Hospital in COVID-19: and Disease 2019 Pulmonary or of Clinical and Among Patients with Post-Acute COVID-19 Analysis of a Nationwide Survey in of Medicine for COVID-19 Syndrome: A Survey of Medicine COVID-19 survivors from and Syndrome from A for COVID-19 to and following recovery from of in common associated with symptoms: a condition 3 months after hospitalisation with SARS-CoV-2 in a prospective cohort COVID and among adults and older adults in the of for an cohort health for from functional in patients with coronavirus admitted to intensive care and the effect of vs on functional COVID-19 on the of health of COVID-19 A post-vaccination of health of COVID-19 A post-vaccination for Hospitalized Adults with between the persistence of post COVID-19 symptoms on patients and the Quality of Health Care Years of in of and in the treatment of in patients after for Patients with COVID-19 Acute Respiratory medical and COVID-19: impact on mortality and hospital of COVID-19 syndrome and its An updated systematic COVID mechanisms and potential therapeutic in COVID ‐19 with symptoms: A review of the literature and of Lung Following COVID-19 in Post-COVID What Do We Know in the Large A characteristics and of health associated with hospital of patients with outcomes of COVID-19 infection in patients with

Topics & Concepts